Clinical Trial Update: DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial of DU-176b in non-valvular atrial fibrillation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Drugs mentioned

• DU-176b

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Atrial Fibrillation, Stroke | Phase 2 | Status: COMPLETED | Results posted: 2015-01-26